Catalyst
Slingshot members are tracking this event:
Myovant Sciences' (MYOV) ORGOVYX (Relugolix) in Uterine fibroids PDUFA date set for June 1, 2021
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MYOV | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 26, 2021
Occurred Source:
https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-and-pfizer-receive-fda-approval-myfembreer
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Orgovyx, Relugolix
